They discovered that PLK2 activity inhibition alters APP and tau pathology and enhances synaptic content in a sex-dependent manner in Alzheimer’s dementia, suggesting that it may contribute to the aetiology of the illness [26]. The gene discussed is PLK2; the disease is Alzheimer disease.